Dealing with multiplicities in pharmacoepidemiologic studies
β Scribed by William F. Rosenberger
- Book ID
- 102660445
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 520 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1053-8569
No coin nor oath required. For personal study only.
β¦ Synopsis
The problem of multiplicities arises in almost all aspects of scientific studies. When multiple hypotheses are tested in a study, one must adjust the significance level of individual tests to maintain an overall probability error rate. The reasons for this are explored in a non-technical way. Techniques for dealing with multiplicities are described and motivated and guidelines are given, with implications for both study design and publication. KEY WORDS -confidence interval estimation; multiple testing problem; p-values; probability error rate; tests of hypothesis; type I error PRELUDE This article discusses statistical hypothesis testing and confidence interval estimation, including the concepts of null and alternative hypotheses, rejection region, type I error, a-level (also called type I error rate or significance level), p-value, and Confidence interval estimation. Any standard statistics textbook will give a good review.'
π SIMILAR VOLUMES
Object Γ Cohort studies in pharmacoepidemiology can result in a unique type of study, where subjects have complex types of exposure to drugs (with periods of non-exposure as well). The object of this paper is to explain how to calculate the sample size of such a study. Method Γ It is assumed that a
Pharmacoepidemiology is the study of the use and the effect of drugs in large numbers of people. The work relies largely on standard epidemiological principles, which, applied in a new context, bring particular constraints and opportunities. In January 1994, a cluster of children with cystic fibrosi